BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 6751532)

  • 1. Review of etoposide single-agent activity.
    Schmoll H
    Cancer Treat Rev; 1982 Jun; 9 Suppl():21-30. PubMed ID: 6751532
    [No Abstract]   [Full Text] [Related]  

  • 2. Podophyllotoxin derivative VP 16-213.
    Arnold AM
    Cancer Chemother Pharmacol; 1979; 3(2):71-80. PubMed ID: 389478
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Etoposide: a new anti-cancer agent.
    Arnold AM; Whitehouse JM
    Lancet; 1981 Oct; 2(8252):912-5. PubMed ID: 6117692
    [No Abstract]   [Full Text] [Related]  

  • 4. VP-16-213 monotherapy for remission induction of small cell lung cancer: a randomized trial using three dosage schedules.
    Cavalli F; Sonntag RW; Jungi F; Senn HJ; Brunner KW
    Cancer Treat Rep; 1978 Mar; 62(3):473-5. PubMed ID: 348319
    [No Abstract]   [Full Text] [Related]  

  • 5. VP16-213 (etoposide). A critical review of its activity.
    Cavalli F
    Cancer Chemother Pharmacol; 1982; 7(2-3):81-5. PubMed ID: 7044594
    [No Abstract]   [Full Text] [Related]  

  • 6. Pediatric cancer chemotherapy: an updated review. I. Cis-Diammine--dichloroplatinum II (cisplatin), VM-26 (teniposide), VP-16 (etoposide), mitomycin C.
    Gutierrez ML; Crooke ST
    Cancer Treat Rev; 1979 Sep; 6(3):153-64. PubMed ID: 394834
    [No Abstract]   [Full Text] [Related]  

  • 7. Phase II clinical trial of weekly administration of VP-16-213 in small cell bronchogenic carcinoma.
    Cohen MH; Broder LE; Fossieck BE; Ihde DC; Minna JD
    Cancer Treat Rep; 1977; 61(3):489-90. PubMed ID: 194694
    [No Abstract]   [Full Text] [Related]  

  • 8. [Etoposide: VP-16].
    Dicato M
    Bull Soc Sci Med Grand Duche Luxemb; 1982; 119(2):15-8. PubMed ID: 7160031
    [No Abstract]   [Full Text] [Related]  

  • 9. VP-16-213. A phase II trial using a weekly schedule.
    Karp G; Antman K; Canellos G
    Cancer Clin Trials; 1981; 4(4):465-7. PubMed ID: 7318129
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Etoposide--an effective single drug for treating bronchogenic carcinoma.
    Anderson G; Peel ET; Cheong CM; Broderick NJ
    Clin Oncol; 1982; 8(3):215-8. PubMed ID: 7140048
    [No Abstract]   [Full Text] [Related]  

  • 11. Etoposide as single agent and in combination with cis-platinum for malignant lymphomas.
    Kroner T; Obrecht JP; Jungi WF
    Cancer Treat Rev; 1982 Jun; 9 Suppl():39-43. PubMed ID: 6889920
    [No Abstract]   [Full Text] [Related]  

  • 12. Etoposide in the treatment of acute leukemia in adults.
    Varini M; Cavalli F; Sauter C
    Cancer Treat Rev; 1982 Jun; 9 Suppl():59-62. PubMed ID: 7127335
    [No Abstract]   [Full Text] [Related]  

  • 13. [Phase II study of etoposide in patients with lung cancer, with special reference to small cell carcinoma].
    Kurita Y; Yokoyama A; Kinameri K; Matsuura N; Sano K
    Nihon Gan Chiryo Gakkai Shi; 1986 Feb; 21(1):108-11. PubMed ID: 3009665
    [No Abstract]   [Full Text] [Related]  

  • 14. [Collaborative phase II study of etoposide (NK-171). Urological Cooperative Study Group of etoposide (NK-171)].
    Gan No Rinsho; 1985 Jul; 31(8):944-52. PubMed ID: 4040986
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Phase II study of etoposide for carcinoma of the prostate.
    Walther PJ; Williams SD; Troner M; Greco FA; Birch R; Einhorn LH
    Cancer Treat Rep; 1986 Jun; 70(6):771-2. PubMed ID: 3524825
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Etoposide: a semisynthetic epipodophyllotoxin. Chemistry, pharmacology, pharmacokinetics, adverse effects and use as an antineoplastic agent.
    Sinkule JA
    Pharmacotherapy; 1984; 4(2):61-73. PubMed ID: 6326063
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Etoposide (VP-16-213).
    Issell BF; Crooke ST
    Cancer Treat Rev; 1979 Jun; 6(2):107-24. PubMed ID: 385138
    [No Abstract]   [Full Text] [Related]  

  • 18. Use of oral VP16-213 as primary chemotherapeutic agent in treatment of gestational trophoblastic disease.
    Wong LC; Choo YC; Ma HK
    Am J Obstet Gynecol; 1984 Dec; 150(8):924-7. PubMed ID: 6095666
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [A phase II study of NK171 (etoposide)].
    Kimura K; Niitani H
    Gan To Kagaku Ryoho; 1985 Oct; 12(10):2011-7. PubMed ID: 2996442
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Etoposide single-agent chemotherapy for solid tumors.
    Jungi WF
    Cancer Treat Rev; 1982 Jun; 9 Suppl():31-7. PubMed ID: 6290055
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.